Ozempic

Study finds patients lost more weight on Mounjaro than Ozempic (NYSE:LLY)

jetcityimage A new study found that patients taking Eli Lilly’s (NYSE:LLY) Mounjaro lost significantly more weight than those taking Novo Nordisk’s (NVO) Ozempic. The study, which analyzed the electronic health records of roughly 41,000 obese or overweight patients who took the drugs, found that the mean loss in body weightContinue Reading

Novo Nordisk’s Ozempic linked to eye disorder (NYSE:NVO)

In: Finance

aprott/iStock via Getty Images There could be an association between Novo Nordisk’s (NVO) popular anti-obesity therapy semaglutide and an eye disorder called NAION (nonarteritic anterior ischemic optic neuropathy), according to a small study published in the medical journal JAMA on Wednesday. The study showed that obese or overweight patients whoContinue Reading

Ozempic

Study finds patients lost more weight on Mounjaro than Ozempic (NYSE:LLY)

Novo Nordisk’s Ozempic linked to eye disorder (NYSE:NVO)

This “robot bird” flies at 45 mph through forests—With no GPS or light

Scientists freeze quantum motion using ultrafast laser trick